摘要
本文综述了在化学合成萜二聚体药理学的进展,从天然化合物。合成萜二聚体分为特定亚组的基础对主要三萜单体骨架结构。二聚体结构的合成萜类衍生物可通过C-3羟基或另一组得到的共价键,VI一个2原子或C-17羧基(主要酸酐、酰胺或酯)。一些三萜类化合物可以发生化学转换导致的环状二聚体或其他类型的二聚体的形成美国的大部分得到三萜二聚体已进行药理试验评价其生物学活性,主要病毒(HIV-1 RT、HCVpp、VSVpp、hiv-rt-c8166-ccr5),细胞毒性(对如388、MCF-7、一定的ncih460,km20l2、DU-145、Hep-G2、A549、BGC-823,PC-3),抗炎(iNOS、原264.7)和糖尿病(rmgpa抑制)。作者还报告了OF部分所获得的循环三萜二聚体认与阴离子形成的自组装结构。
关键词: 三萜类、三萜二聚体,二聚衍生物,合成二聚体、萜类、三萜类化合物的药理活性。
Current Medicinal Chemistry
Title:Advances in Chemistry and Pharmacology of Triterpenoid Synthetic Dimers
Volume: 24 Issue: 20
关键词: 三萜类、三萜二聚体,二聚衍生物,合成二聚体、萜类、三萜类化合物的药理活性。
摘要: This review focuses on advances in chemistry and pharmacology of synthetic triterpenoid dimers, obtained from natural compounds. Synthetic triterpenoid dimers are divided into specific subgroups based on the structure of main triterpenoid monomeric skeleton. Synthetic triterpenoid derivatives of dimeric structure can be obtained through the covalent linkage of the C-3 hydroxyl or another group, via the C-2 atom or the C-17 carboxyl group (mainly anhydrides, amides or esters). Some triterpenes can undergo chemical transformations leading to the formation of cyclic dimers or other types of dimers. Most of the obtained triterpenoid dimers have been subjected to pharmacological tests evaluating their biological activity, mainly antiviral (HIV-1 RT, HCVpp, VSVpp, HIV-RT-C8166-CCR5), cytotoxic (against e.g. 388, MCF-7, SF-268, NCIH460, KM20L2, DU-145, Hep-G2, A549, BGC-823, PC-3), anti-inflammatory (iNOS, RAW 264.7) and antidiabetic (RMGPa inhibition). The authors also reported the ability of some of the obtained cyclic triterpenoid dimers to recognize anions and to form self-assembled structures.
Export Options
About this article
Cite this article as:
Advances in Chemistry and Pharmacology of Triterpenoid Synthetic Dimers, Current Medicinal Chemistry 2017; 24 (20) . https://dx.doi.org/10.2174/0929867324666170202151625
DOI https://dx.doi.org/10.2174/0929867324666170202151625 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Network Insights into the Genes Regulated by Hepatocyte Nuclear Factor 4 in Response to Drug Induced Perturbations: A Review
Current Drug Discovery Technologies An Overview on 2-arylquinolin-4(1H)-ones and Related Structures as Tubulin Polymerisation Inhibitors
Current Topics in Medicinal Chemistry Cancer Stem Cells in Prostate Cancer Chemoresistance
Current Cancer Drug Targets Polycystic Ovary Syndrome in Adolescents
Current Women`s Health Reviews Obesity and Cancer: Biological Links and Treatment Implications
Current Cancer Drug Targets Natural Compounds in Anti-Leukaemic Therapy: A Review
Mini-Reviews in Medicinal Chemistry Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets Role of Hsp70 in Cancer Growth and Survival
Protein & Peptide Letters HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Current Pharmaceutical Design Obesity and Diabetes Gene Discovery Approaches
Current Pharmaceutical Design Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Molecular Recognition of Natural Products by Resorc[4]arene Receptors
Current Pharmaceutical Design MicroRNAs in Cancer Gene Therapy: Another Look
Current Cancer Therapy Reviews Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Current Drug Targets The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Genes and Gene Sequences Useful for Developing Breast Cancer Detection Systems
Recent Patents on DNA & Gene Sequences Metabolic Targeting of Cancers: From Molecular Mechanisms to Therapeutic Strategies
Current Medicinal Chemistry Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry Therapeutic Proteins: A to Z
Protein & Peptide Letters Pancreatic Neoplasms and Autophagy
Current Drug Targets